National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Lisinopril
Synonyms

N2-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline, Dihydrate

LISINOPRIL

Lisinopril

Prinivil

Zestril

lisinopril

Definitions

An orally bioavailable, long-acting angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Lisinopril, a synthetic peptide derivative, specifically and competitively inhibits ACE, which results in a decrease in the production of the potent vasoconstrictor angiotensin II and, so, diminished vasopressor activity. In addition, angiotensin II-stimulated aldosterone secretion by the adrenal cortex is decreased which results in a decrease in sodium and water retention and an increase in serum potassium.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29159

ALT_DEFINITION

A drug used to treat high blood pressure and certain heart conditions. It is also being studied in the prevention and treatment of side effects caused by some anticancer drugs. It blocks certain enzymes that cause blood vessels to constrict (narrow). It is a type of angiotensin-converting enzyme (ACE) inhibitor.

CAS_Registry

83915-83-7

CHEBI_ID

CHEBI:6503

Chemical_Formula

C21H31N3O5.2H2O

code

C29159

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

CTRP

FDA

DEFINITION

An orally bioavailable, long-acting angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Lisinopril, a synthetic peptide derivative, specifically and competitively inhibits ACE, which results in a decrease in the production of the potent vasoconstrictor angiotensin II and, so, diminished vasopressor activity. In addition, angiotensin II-stimulated aldosterone secretion by the adrenal cortex is decreased which results in a decrease in sodium and water retention and an increase in serum potassium.

Display_Name

Lisinopril

FDA_UNII_Code

E7199S1YWR

FULL_SYN

N2-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline, Dihydrate

LISINOPRIL

Lisinopril

Prinivil

Zestril

lisinopril

Has_Target

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91297

label

Lisinopril

Legacy Concept Name

Lisinopril

NCI_Drug_Dictionary_ID

658710

PDQ_Closed_Trial_Search_ID

658710

PDQ_Open_Trial_Search_ID

658710

Preferred_Name

Lisinopril

prefixIRI

Thesaurus:C29159

Semantic_Type

Organic Chemical

Pharmacologic Substance

UMLS_CUI

C0065374

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C247

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/XCO_0000535 XCO LOOM
http://purl.bioontology.org/ontology/RXNORM/29046 NLMVS LOOM
http://purl.bioontology.org/ontology/RXNORM/29046 RXNORM LOOM
http://purl.bioontology.org/ontology/CSP/4008-0060 CRISP LOOM
http://purl.bioontology.org/ontology/ATC/C09AA03 ATC LOOM
http://www.drugbank.ca/drugs/DB00722 FTC LOOM
http://purl.jp/bio/4/id/200906049575118769 IOBC LOOM
http://purl.obolibrary.org/obo/OMIT_0018011 OMIT LOOM
http://purl.bioontology.org/ontology/VANDF/4019380 VANDF LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000658710 PDQ LOOM
https://go.drugbank.com/drugs/DB00722 MDM LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386873009 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000147537 NDFRT LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000147537 ODAE LOOM
http://www.phoc.org.cn/pmo/class/PMO_00021390 PMAPP-PMO LOOM
http://bmi.utah.edu/ontologies/hfontology/C0065374 HFO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 CCONT LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 COVID-19 LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 CIDO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 NIFSTD LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 HINO LOOM
http://purl.obolibrary.org/obo/CHEBI_43755 ODNAE LOOM
http://stirdf.jst.go.jp/id/200907032905020144 IOBC LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0065374 OCHV LOOM
http://www.co-ode.org/ontologies/galen#Lisinopril GALEN LOOM
http://purl.bioontology.org/ontology/NDDF/000658 NDDF LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D12.644.456.345.600 RH-MESH LOOM
http://purl.bioontology.org/ontology/MESH/D017706 MESH LOOM
http://mimi.case.edu/ontologies/2009/9/DrugOntology#lisinopril SDO LOOM
http://purl.bioontology.org/ontology/RCD/bi3.. RCD LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#14325 OCHV LOOM
http://purl.obolibrary.org/obo/NCIT_C29159 BERO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D017706 RH-MESH LOOM
http://purl.obolibrary.org/obo/MESH_D017706 BERO LOOM
http://purl.bioontology.org/ontology/LNC/LP171618-4 LOINC LOOM